Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabhavathi Fernandes

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Efforts to support the development of fusidic acid in the United StatesPrabhavathi Fernandes, David Pereira
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2014
Antibiotic usage and the development of resistancePrabhavathi Fernandes, David Oldach
Biochemical Pharmacology|October 1, 2016
Antibiotics in late clinical developmentPrabhavathi Fernandes, Evan Martens
The Lancet. Infectious Diseases|September 4, 2019
Phase 3 trial of treating gonorrhoea with solithromycinPrabhavathi Fernandes, J Carl Craft
The Journal of Antibiotics|December 1, 2016
Nature nurtures the design of new semi-synthetic macrolide antibioticsPrabhavathi Fernandes, Evan Martens, David Pereira
Antimicrobial Agents and Chemotherapy|March 19, 2014
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strainsJørgen Skov Jensen, Prabhavathi Fernandes, Magnus Unemo
Antimicrobial Agents and Chemotherapy|September 14, 2016
In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory PathogenDwight J Hardy, David Vicino, Prabhavathi Fernandes
Antimicrobial Agents and Chemotherapy|April 15, 2015
Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic ImpairmentBrian D Jamieson, Sabrina Ciric, Prabhavathi Fernandes
Bioorganic & Medicinal Chemistry|September 6, 2016
The solithromycin journey-It is all in the chemistryPrabhavathi Fernandes, Evan Martens, Daniel Bertrand, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptorsDaniel Bertrand, Sonia Bertrand, Estelle Neveu, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Efforts to support the development of fusidic acid in the United StatesPrabhavathi Fernandes, David Pereira
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2014
Antibiotic usage and the development of resistancePrabhavathi Fernandes, David Oldach
Biochemical Pharmacology|October 1, 2016
Antibiotics in late clinical developmentPrabhavathi Fernandes, Evan Martens
The Lancet. Infectious Diseases|September 4, 2019
Phase 3 trial of treating gonorrhoea with solithromycinPrabhavathi Fernandes, J Carl Craft
The Journal of Antibiotics|December 1, 2016
Nature nurtures the design of new semi-synthetic macrolide antibioticsPrabhavathi Fernandes, Evan Martens, David Pereira
Antimicrobial Agents and Chemotherapy|March 19, 2014
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strainsJørgen Skov Jensen, Prabhavathi Fernandes, Magnus Unemo
Antimicrobial Agents and Chemotherapy|September 14, 2016
In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory PathogenDwight J Hardy, David Vicino, Prabhavathi Fernandes
Antimicrobial Agents and Chemotherapy|April 15, 2015
Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic ImpairmentBrian D Jamieson, Sabrina Ciric, Prabhavathi Fernandes
Bioorganic & Medicinal Chemistry|September 6, 2016
The solithromycin journey-It is all in the chemistryPrabhavathi Fernandes, Evan Martens, Daniel Bertrand, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptorsDaniel Bertrand, Sonia Bertrand, Estelle Neveu, et al.
Pageof 6